NUGALVIQ

Serial Number 99400186
630

Registration Progress

Application Filed
Sep 18, 2025
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

NUGALVIQ

Basic Information

Serial Number
99400186
Filing Date
September 18, 2025
Drawing Code
3

Status Summary

Current Status
Active
Status Code
630
Status Date
Sep 18, 2025
Application
Pending
Classes
005

Rights Holder

Applied Therapeutics, Inc.

03
Address
545 Fifth Avenue, Suite 1400
New York, NY 10017

Ownership History

Applied Therapeutics, Inc.

Original Applicant
03
New York, NY

Legal Representation

Attorney
Anna Kurian Shaw

Application History

2 events
Date Code Type Description Documents
Sep 18, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Sep 18, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for treatment of rare orphan diseases; Pharmaceutical preparations for treatment of diseases that impact sugar and glucose metabolism; Pharmaceutical preparations for inhibiting aldose reductase; Pharmaceutical preparations for treatment of galactosemia, sorbitol dehydrogenase (SORD) deficiency and PMM2-congenital disorder of glycosylation (PMM2-CDG)

Additional Information

Design Mark
The mark consists of three curved vertical lines consisting of dots of graduated sizes, with the word "NUGALVIQ" to the right of the design.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005